PROFUSA, INC. Equity, Fair Value Disclosure
PROFUSA, INC. (PFSA) had Equity, Fair Value Disclosure of $155.00 million as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:EquityFairValueDisclosure · last filed 2023-11-20
- 2023-09-30: Equity, Fair Value Disclosure $155.00M.
- 2023-06-30: Equity, Fair Value Disclosure $155.00M.
- 2023-03-31: Equity, Fair Value Disclosure $155.00M.
- 2022-12-31: Equity, Fair Value Disclosure $155.00M.
| Period end | Equity, Fair Value Disclosure |
|---|---|
| 2023-09-30 | $155.00M 10-Q · filed 2023-11-20 |
| 2023-06-30 | $155.00M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $155.00M 10-Q · filed 2023-05-17 |
| 2022-12-31 | $155.00M 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |